Total Payments
$9,277
2024 Payments
$2,043
Companies
37
Transactions
562
Medicare Patients
1,631
Medicare Billing
$169,162
Payment Breakdown by Category
Food & Beverage$9,252 (99.7%)
Consulting$18.83 (0.2%)
Education$6.61 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,252 | 560 | 99.7% |
| Consulting Fee | $18.83 | 1 | 0.2% |
| Education | $6.61 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,931 | 164 | $0 (2024) |
| ABBVIE INC. | $1,444 | 79 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $633.93 | 20 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $604.32 | 48 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $529.77 | 36 | $0 (2022) |
| GENZYME CORPORATION | $424.69 | 14 | $0 (2024) |
| QOL Medical, LLC | $416.84 | 29 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $368.25 | 26 | $0 (2018) |
| Allergan, Inc. | $347.92 | 23 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $325.16 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,043 | 83 | Phathom Pharmaceuticals, Inc. ($633.93) |
| 2023 | $1,157 | 73 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($395.05) |
| 2022 | $865.32 | 57 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($336.94) |
| 2021 | $1,022 | 66 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($352.15) |
| 2020 | $552.16 | 44 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($220.65) |
| 2019 | $1,179 | 87 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($401.74) |
| 2018 | $1,456 | 95 | Synergy Pharmaceuticals Inc ($310.78) |
| 2017 | $1,003 | 57 | Merck Sharp & Dohme Corporation ($167.74) |
All Payment Transactions
562 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/30/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/16/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $36.92 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/03/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $14.88 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $17.58 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $50.78 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 423 | 461 | $187,554 | $45,463 |
| 2022 | 9 | 492 | 547 | $205,805 | $52,035 |
| 2021 | 9 | 425 | 472 | $190,131 | $44,652 |
| 2020 | 7 | 291 | 325 | $156,010 | $27,012 |
Total Patients
1,631
Total Services
1,805
Medicare Billing
$169,162
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 34 | 35 | $26,985 | $7,713 | 28.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 69 | 70 | $51,730 | $7,593 | 14.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 96 | $14,304 | $6,814 | 47.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 72 | 72 | $13,320 | $6,769 | 50.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 78 | 79 | $50,086 | $6,095 | 12.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 49 | $10,339 | $5,028 | 48.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $14,000 | $1,994 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,878 | $1,924 | 49.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 32 | $2,912 | $1,533 | 52.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 40 | 41 | $31,611 | $8,689 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 114 | $16,986 | $8,633 | 50.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 74 | 76 | $56,164 | $7,789 | 13.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 74 | 74 | $13,690 | $7,283 | 53.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 67 | $14,137 | $7,126 | 50.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 79 | 83 | $52,622 | $6,634 | 12.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 54 | 65 | $5,915 | $3,163 | 53.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $13,000 | $1,888 | 14.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 14 | 14 | $1,680 | $829.23 | 49.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 90 | 125 | $19,951 | $9,760 | 48.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 56 | 56 | $45,072 | $6,584 | 14.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 78 | 80 | $54,736 | $6,352 | 11.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 28 | 28 | $25,020 | $6,348 | 25.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 59 | 59 | $11,485 | $5,379 | 46.8% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 20 | 20 | $20,000 | $3,305 | 16.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 50 | 59 | $5,913 | $2,872 | 48.6% |
About Dr. Michael Bloom, M.D
Dr. Michael Bloom, M.D is a Gastroenterology healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306834171.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bloom, M.D has received a total of $9,277 in payments from pharmaceutical and medical device companies, with $2,043 received in 2024. These payments were reported across 562 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($9,252).
As a Medicare-enrolled provider, Bloom has provided services to 1,631 Medicare beneficiaries, totaling 1,805 services with total Medicare billing of $169,162. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Miami Beach, FL
- Active Since 10/06/2005
- Last Updated 02/21/2008
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1306834171
Products in Payments
- XIFAXAN (Drug) $1,446
- VOQUEZNA (Drug) $633.93
- LINZESS (Drug) $614.17
- DUPIXENT (Biological) $518.70
- Trulance (Drug) $368.25
- TRULANCE (Drug) $338.54
- Mavyret (Drug) $316.37
- CLENPIQ (Drug) $306.67
- RINVOQ (Biological) $294.13
- Linzess (Drug) $293.71
- MAVYRET (Drug) $290.35
- Sucraid (Drug) $210.35
- SUCRAID (Drug) $206.49
- INJECTAFER (Drug) $200.99
- CREON (Drug) $187.06
- ZEPOSIA (Drug) $184.99
- OCALIVA (Drug) $177.86
- VIBERZI (Drug) $162.69
- IBSRELA (Drug) $158.08
- ZENPEP (Drug) $152.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Miami Beach
Hernando Gonzalez Quiros, M.d, M.D
Gastroenterology — Payments: $29,855
Gastroenterology $29,855
Dr. Isaac Bassan, M.d, M.D
Gastroenterology — Payments: $16,493
Gastroenterology $16,493
Dr. Jonathan Mazurek, M.d, M.D
Gastroenterology — Payments: $14,893
Gastroenterology $14,893
Frank Czul Gurdian, M.d, M.D
Gastroenterology — Payments: $13,124
Gastroenterology $13,124
Manuel Berzosa Corella, M.d, M.D
Gastroenterology — Payments: $12,307
Gastroenterology $12,307
Dr. Robert Goldberg, Md, MD
Gastroenterology — Payments: $10,227
Gastroenterology $10,227